Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) FCF Margin (2016 - 2025)

Historic FCF Margin for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to 1.94%.

  • International Stem Cell's FCF Margin fell 81500.0% to 1.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.48%, marking a year-over-year decrease of 24500.0%. This contributed to the annual value of 1.68% for FY2024, which is 125800.0% down from last year.
  • As of Q3 2025, International Stem Cell's FCF Margin stood at 1.94%, which was down 81500.0% from 13.57% recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's FCF Margin peaked at 23.85% during Q2 2023, and registered a low of 23.76% during Q1 2021.
  • In the last 5 years, International Stem Cell's FCF Margin had a median value of 1.94% in 2025 and averaged 1.06%.
  • In the last 5 years, International Stem Cell's FCF Margin tumbled by -348700bps in 2021 and then soared by 292800bps in 2022.
  • International Stem Cell's FCF Margin (Quarter) stood at 17.69% in 2021, then soared by 118bps to 3.25% in 2022, then soared by 162bps to 8.52% in 2023, then crashed by -136bps to 3.07% in 2024, then soared by 163bps to 1.94% in 2025.
  • Its FCF Margin stands at 1.94% for Q3 2025, versus 13.57% for Q2 2025 and 10.43% for Q1 2025.